Reusable Syringe Global Market Report 2026

A reusable syringe is a medical injection instrument designed for repeated use after sterilization rather than disposal following a single application. It generally includes a robust barrel, plunger, and needle manufactured from materials such as glass or metal that are capable of tolerating repeated cleaning and sterilization procedures. These syringes contribute to lower long-term operating expenses and help reduce the volume of medical waste compared to disposable syringe alternatives.

The primary types of reusable syringes include standard reusable syringes, safety-enhanced reusable syringes, insulin-specific reusable syringes, and enteral reusable syringes. Standard reusable syringes are durable injection devices designed for repeated sterilization and multiple clinical or laboratory applications. These syringes are manufactured using materials such as stainless steel, plastic, and glass and are available in different capacities including low-volume (up to one milliliter), medium volume (one milliliter to twenty milliliters), and high-volume (above twenty milliliters). Their applications include vaccination procedures, insulin administration, hormonal treatments, and intravenous therapies, and their end users include hospitals and clinics, veterinary facilities, diagnostic and research laboratories, pharmaceutical organizations, academic institutions, and industrial users.

Tariffs are influencing the reusable syringe market by increasing the cost of imported stainless steel, glass, plastic polymers, precision needles, and manufacturing equipment required for syringe production. This is generating upward pricing pressure across product categories such as standard reusable syringes, safety syringes, insulin syringes, and enteral syringes, while also raising procurement costs for healthcare providers. Regions with strong reliance on imported medical components, particularly North America, Europe, and parts of Asia-Pacific, are facing supply chain disruptions and elevated operational expenses. However, tariffs are simultaneously encouraging the development of domestic manufacturing facilities, supplier diversification, and greater investment in local medical device production capabilities, reinforcing long-term supply stability.

The reusable syringe market size has grown strongly in recent years. It will grow from $2.24 billion in 2025 to $2.43 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising healthcare spending, expanded utilization of reusable medical devices, increased emphasis on minimizing medical waste, scaling of immunization programs, and economic benefits from multi-use devices.

The reusable syringe market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth over the forecast period can be attributed to advancements in durable syringe material technologies, increasing demand for sustainable healthcare product alternatives, growing adoption across emerging healthcare markets, expansion of research and diagnostic laboratory activities, and strengthening of sterilization and infection control infrastructure. Major trends during the forecast period include rising adoption of sterilizable long-life syringe materials, growing demand for reusable syringes in cost-sensitive healthcare environments, increasing preference for safety-engineered reusable syringe designs, expansion of reusable syringe usage in veterinary and laboratory applications, and enhanced focus on reducing medical waste through reusable injection device adoption.

The growing emphasis on minimizing medical waste is expected to drive the growth of the reusable syringe market going forward. Medical waste refers to any form of waste generated from healthcare activities, including used syringes, bandages, medical equipment, and contaminated materials that may present health or environmental hazards. The increasing focus on reducing medical waste is being driven by rising environmental concerns and stricter regulatory frameworks, as healthcare systems aim to reduce pollution, enhance safety, and adopt sustainable waste management approaches. Efforts to reduce medical waste are boosting the adoption of reusable syringes by encouraging healthcare providers to shift toward durable, sterilizable alternatives that reduce single-use plastic waste and enhance sustainability in healthcare practices. For instance, in March 2023, according to NHS Digital, a UK government health data and statistical authority, providers generate around 156,000 tonnes of clinical waste annually, which is either processed through high-temperature incineration (HTI) or alternative treatment (AT), a quantity equivalent to more than 400 fully loaded jumbo jets of waste. Therefore, the rising focus on reducing medical waste is driving the growth of the reusable syringe market.

Key companies operating in the reusable syringe market are focusing on developing innovative products, such as over-the-counter (OTC) reusable enteral syringes to improve medication and feeding delivery efficiency. Reusable syringes are medical-grade injection or delivery devices designed for multiple uses after proper cleaning and sterilization, offering durable construction, accurate dosage measurement, and compatibility with enteral feeding systems such as ENFit connectors. For example, in January 2026, ENvue Medical Inc., a US-based medical device company, launched a new line of OTC ENFit reusable syringes designed for both enteral feeding and medication delivery applications. The product line is available in multiple sizes, including 2.5 mL, 5 mL, 10 mL, and 60 mL variants, and is designed for prescription-free access through online retail platforms and durable medical equipment channels. These syringes are engineered to ensure secure ENFit-compatible connections, improved dosing accuracy, and ease of use in homecare settings, supporting safer and more efficient patient-managed enteral nutrition and medication administration.

In January 2026, ENvue Medical Inc., a US-based medical technology company focused on manufacturing reusable ENFit syringes, entered into a partnership with U-Deliver to broaden the distribution of its ENFit syringe offerings across home care and long-term care markets in the United States. Through this collaboration, ENvue Medical and U-Deliver plan to utilize U-Deliver's digital platform and wholesale distribution network to enhance availability of ENvue's ENFit syringes, which are designed to ensure safe and consistent enteral feeding and medication administration in both clinical and home-care settings without the need for a prescription. U-Deliver LLC is a US-based supplier and distributor of enteral feeding products for home healthcare and long-term care environments.

Major companies operating in the reusable syringe market are Sanofi S.A., Novo Nordisk A/S, Eli Lilly and Company, Neogen Corporation, Gerresheimer AG, Datwyler Holding Inc., Ypsomed Holding AG, SHL Medical AG, Trajan Scientific and Medical, Hamilton Company, Vygon SA, Nemera France SAS, Owen Mumford Ltd., Cadence Inc., Henke Sass Wolf GmbH, Jorgen Kruuse UK Ltd., ENvue Medical (USA) Inc., Socorex Isba SA, ARDES Group, Portal Instruments Inc.

North America was the dominant region in the reusable syringe market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in reusable syringe report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the reusable syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reusable syringe market consists of sales of reusable syringe barrels, syringe assemblies, precision dosing syringes, multi-use injection syringes, autoclavable syringes, calibrated reusable syringes, and reusable fluid administration syringes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The reusable syringe market research report is one of a series of new reports from The Business Research Company that provides reusable syringe market statistics, including reusable syringe industry global market size, regional shares, competitors with a reusable syringe market share, detailed reusable syringe market segments, market trends and opportunities, and any further data you may need to thrive in the reusable syringe industry. This reusable syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Reusable Syringe Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses reusable syringe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for reusable syringe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The reusable syringe market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Standard Reusable Syringes; Safety Reusable Syringes; Insulin Reusable Syringes; Enteral Reusable Syringes
• 2) By Material: Stainless Steel; Plastic; Glass
• 3) By Volume Capacity: Low Volume Up To One Milliliter; Standard Volume One Milliliter To Twenty Milliliters; High Volume Above Twenty Milliliters
• 4) By Application: Vaccination; Insulin Delivery; Hormonal Therapy; Intravenous Therapy
• 5) By End User: Hospitals And Clinics; Veterinary Clinics; Research And Diagnostic Laboratories; Pharmaceutical Companies; Academic And Training Institutes; Industrial Users
• Subsegments:
• 1) By Standard Reusable Syringes: Glass Standard Reusable Syringes; Metal Standard Reusable Syringes; Plastic Standard Reusable Syringes; Multi Dose Standard Reusable Syringes; Precision Standard Reusable Syringes
• 2) By Safety Reusable Syringes: Retractable Safety Reusable Syringes; Needle Shield Safety Reusable Syringes; Locking Mechanism Safety Reusable Syringes; Passive Safety Reusable Syringes; Active Safety Reusable Syringes
• 3) By Insulin Reusable Syringes: Low Dose Insulin Reusable Syringes; High Dose Insulin Reusable Syringes; Fine Needle Insulin Reusable Syringes; Adjustable Dose Insulin Reusable Syringes; Pen Compatible Insulin Reusable Syringes
• 4) By Enteral Reusable Syringes: Catheter Tip Enteral Reusable Syringes; Oral Tip Enteral Reusable Syringes; Large Volume Enteral Reusable Syringes; Feeding Tube Enteral Reusable Syringes; Enfit Compatible Enteral Reusable Syringes
• Companies Mentioned: Sanofi S.A.; Novo Nordisk A/S; Eli Lilly and Company; Neogen Corporation; Gerresheimer AG; Datwyler Holding Inc.; Ypsomed Holding AG; SHL Medical AG; Trajan Scientific and Medical; Hamilton Company; Vygon SA; Nemera France SAS; Owen Mumford Ltd.; Cadence Inc.; Henke Sass Wolf GmbH; Jorgen Kruuse UK Ltd.; ENvue Medical (USA) Inc.; Socorex Isba SA; ARDES Group; Portal Instruments Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.